{"id":"https://openalex.org/W2230727618","doi":"https://doi.org/10.1200/jco.2008.26.15_suppl.3059","title":"Dose-response study of a cryopreserved, autologous, hapten-modified melanoma vaccine (Mvax)","display_name":"Dose-response study of a cryopreserved, autologous, hapten-modified melanoma vaccine (Mvax)","publication_year":2008,"publication_date":"2008-05-20","ids":{"openalex":"https://openalex.org/W2230727618","doi":"https://doi.org/10.1200/jco.2008.26.15_suppl.3059","mag":"2230727618"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2008.26.15_suppl.3059","doi":"https://doi.org/10.1200/jco.2008.26.15_suppl.3059","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2008.26.15_suppl.3059","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5045802455","display_name":"David Berd","orcid":"https://orcid.org/0000-0003-2974-9085","observed_orcids":["https://orcid.org/0000-0003-2974-9085"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D. Berd","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013272775","display_name":"Ellen Bloome","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E. Bloome","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019272479","display_name":"H. Schea","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H. Schea","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055628758","display_name":"B. Pinteur","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"B. Pinteur","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110235804","display_name":"Fran\u00e7ois Fossiez","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"F. Fossiez","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007911311","display_name":"Eduardo P\u00e9rez Garc\u00eda","orcid":"https://orcid.org/0000-0002-6636-3635","observed_orcids":["https://orcid.org/0000-0002-6636-3635"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E. Garcia","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5054622416","display_name":"Lionel Chalus","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L. Chalus","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"26","issue":"15_suppl","first_page":"3059","last_page":"3059"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9883000254631042,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9883000254631042,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.009399999864399433,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/melanoma-vaccine","display_name":"melanoma vaccine","score":0.8870000243186951},{"id":"https://openalex.org/keywords/autologous-tumor-cells","display_name":"autologous tumor cells","score":0.8669999837875366},{"id":"https://openalex.org/keywords/dinitrophenyl","display_name":"dinitrophenyl","score":0.9829999804496765},{"id":"https://openalex.org/keywords/cryopreservation","display_name":"cryopreservation","score":0.9010000228881836},{"id":"https://openalex.org/keywords/dose-response-relationship","display_name":"dose-response relationship","score":0.6660000085830688},{"id":"https://openalex.org/keywords/delayed-type-hypersensitivity","display_name":"delayed-type hypersensitivity","score":0.9670000076293945},{"id":"https://openalex.org/keywords/t-cell-mediated-immunity","display_name":"T cell immunity","score":0.8730000257492065},{"id":"https://openalex.org/keywords/metastatic-melanoma","display_name":"metastatic melanoma","score":0.9570000171661377},{"id":"https://openalex.org/keywords/bcg-adjuvant","display_name":"BCG adjuvant","score":0.8610000014305115},{"id":"https://openalex.org/keywords/cyclophosphamide","display_name":"cyclophosphamide","score":0.9869999885559082},{"id":"https://openalex.org/keywords/vaccine-safety","display_name":"vaccine safety","score":0.7799999713897705},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.46299999952316284},{"id":"https://openalex.org/keywords/immunogenicity","display_name":"immunogenicity","score":0.3619999885559082},{"id":"https://openalex.org/keywords/immunocompetent-patient","display_name":"immunocompetent patient","score":0.5090000033378601}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8863780498504639},{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.6866011619567871},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.5037521719932556},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.4716355502605438},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4333685040473938},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.36541491746902466},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2080080807209015},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.10903245210647583}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2008.26.15_suppl.3059","doi":"https://doi.org/10.1200/jco.2008.26.15_suppl.3059","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2008.26.15_suppl.3059","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2108838987","https://openalex.org/W1994589626","https://openalex.org/W1976234101","https://openalex.org/W1968375892","https://openalex.org/W1977891449","https://openalex.org/W2084378334","https://openalex.org/W4248723346","https://openalex.org/W1974607314","https://openalex.org/W1991915223","https://openalex.org/W2145514352"],"abstract_inverted_index":{"3059":[0],"Background:":[1],"A":[2,107],"vaccine":[3,95,120,134,164,243],"consisting":[4],"of":[5,57,93,119,133,163,168,229,242],"autologous":[6,72,147,280],"tumor":[7,22,103,148],"cells":[8,104,282],"modified":[9,35,59,258],"with":[10,78,136],"the":[11,21,58,161,207,211,240,246,289],"hapten,":[12],"dinitrophenyl":[13],"(DNP)":[14],"induces":[15,68],"T":[16,276],"cell-":[17],"mediated":[18],"immunity":[19,278],"to":[20,61,71,91,146,199,222,279],"cells,":[23,149],"as":[24,224],"measured":[25],"by":[26,124,129,174,201],"delayed-type":[27],"hypersensitivity":[28],"(DTH).":[29],"The":[30,166,255,271],"manufacturing":[31],"process":[32],"has":[33],"been":[34],"so":[36],"that":[37,63],"vaccines":[38],"are":[39,204],"cryopreserved":[40],"immediately":[41],"after":[42,160],"preparation":[43],"and":[44,67,138,153,159,190,245],"stored":[45],"at":[46,141],"-70\u00b0":[47],"until":[48],"administered.":[49],"We":[50],"herein":[51],"report":[52],"a":[53,88,139,175,235,294],"phase":[54,297],"I-II":[55],"trial":[56],"product":[60],"confirm":[62],"it":[64],"is":[65],"safe":[66],"DTH":[69,144,188,193,197,220,248],"responses":[70,145,189,198,221,249],"melanoma":[73,84,259,281],"cells.":[74],"Methods:":[75],"Immunocompetent":[76],"patients":[77,184,217,233],"stage":[79],"IIIB,":[80],"IIIC,":[81],"or":[82,101,335,338],"IV":[83],"were":[85,156],"assigned":[86],"in":[87,206,261,268],"double-blinded":[89],"manner":[90],"one":[92],"four":[94],"dosage":[96,170,202,213,291],"arms:":[97],"5.0\u00d7106,":[98],"2.5\u00d7106,":[99],"0.5\u00d7106,":[100],"0":[102,310,313,325],"(diluent":[105],"only).":[106],"previously":[108],"optimized":[109],"treatment":[110],"schedule":[111],"was":[112,172,265],"followed,":[113],"which":[114],"included":[115],"an":[116],"\u201cinduction\u201d":[117],"dose":[118,273],"without":[121,283],"adjuvant,":[122],"followed":[123,128],"cyclophosphamide":[125],"300":[126],"mg/m2,":[127],"6":[130,142],"weekly":[131],"injections":[132],"mixed":[135],"BCG":[137],"boost":[140],"months.":[143],"both":[150],"DNP-modified":[151],"(DNP-TC)":[152],"unmodified":[154],"(UN-TC),":[155],"tested":[157,218,274],"before":[158],"course":[162],"administration.":[165],"efficacy":[167],"each":[169],"level":[171],"analyzed":[173],"two-step":[176],"design.":[177],"Results:":[178],"From":[179],"8":[180,311,318],"clinical":[181],"sites,":[182],"63":[183,231],"had":[185],"negative":[186],"baseline":[187],"completed":[191],"post-vaccine":[192,196],"testing.":[194],"Their":[195],"DNP-TC":[200],"arm":[203],"shown":[205],"Table":[208],"below.":[209],"In":[210],"5.0\u00d7106":[212],"arm,":[214],"9/24":[215],"(38%)":[216],"developed":[219],"UN-TC":[223],"well.":[225],"Linear":[226],"regression":[227],"analysis":[228],"all":[230],"evaluable":[232],"indicated":[234],"significant":[236],"direct":[237],"relationship":[238],"between":[239],"doses":[241],"administered":[244],"post-treatment":[247],"(squared":[250],"multiple":[251],"R=0.446,":[252],"p<.001).":[253],"Conclusions:":[254],"autologous,":[256],"hapten-":[257],"vaccine,":[260],"its":[262],"frozen":[263],"form,":[264],"immunologically":[266],"active":[267],"metastatic":[269],"melanoma.":[270],"highest":[272],"induced":[275],"cell":[277],"serious":[284],"toxicity;":[285],"these":[286],"results":[287],"define":[288],"appropriate":[290],"range":[292],"for":[293],"recently":[295],"initiated":[296],"III":[298],"randomized":[299],"trial.":[300],"Dosage":[301],"Arm":[302],"Total":[303],"No.":[304],"(+)":[305],"(\u22655":[306],"mm":[307],"induration)":[308],"Effective":[309],"2":[312],"0.5":[314],"\u00d7":[315,321,327],"106":[316,322,328],"16":[317],"+":[319],"2.5":[320],"10":[323],"4":[324],"5.0":[326],"29":[329],"22":[330],"++":[331],"Author":[332],"Disclosure":[333],"Employment":[334],"Leadership":[336],"Consultant":[337],"Advisory":[339],"Role":[340],"Stock":[341],"Ownership":[342],"Honoraria":[343],"Research":[344],"Expert":[345],"Testimony":[346],"Other":[347],"Remuneration":[348],"AVAX":[349,351],"Technologies":[350,352]},"counts_by_year":[{"year":2023,"cited_by_count":1}],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2016-06-24T00:00:00"}